Here is Why Beam Therapeutics (BEAM) Appears so Attractive

Beam Therapeutics (NASDAQ:BEAM) is 1 of the 17 biotechnology stocks with much than 50% upside.

On January 22, Patrick Trucchio from H.C. Wainwright maintained a Buy standing connected Beam Therapeutics (NASDAQ:BEAM), with a terms people of $80. This results successful a highly charismatic upside imaginable of much than 197%.

Looker_Studio/Shutterstock.com

Trucchio’s standing is based connected respective factors linked with the company’s objective and regulatory progress. He noted the company’s caller statement with the U.S. FDA to expedite the support process for BEAM-302 successful alpha-1 antitrypsin deficiency. This would alteration the usage of AAT biomarker information implicit a 12‑month horizon, which would service arsenic a superior ground for the aboriginal BLA.

The expert besides reflected favorably connected the company’s awesome fiscal standing, backed by a coagulated currency and marketable securities equilibrium of astir $1.25 cardinal arsenic of the extremity of 2025. As per his assessments, this equilibrium should beryllium capable to concern concern operations till 2029, money the improvement of BEAM-302, and screen the anticipated motorboat of risto-cel.

Back connected January 8, Beam Therapeutics (NASDAQ:BEAM) was assigned a Neutral standing with a $28 terms people by UBS expert Michael Yee. The expert anticipates much certainty for investors, which sets the signifier for the biotech assemblage to bash good successful 2026. Going forward, helium expects large catalysts and charismatic pipelines to thrust the conception returns.

Beam Therapeutics (NASDAQ:BEAM) is simply a biotechnology institution that develops precision familial medicines and besides engages successful cistron therapies and genome editing research. Since its launch, Beam Therapeutics (NASDAQ:BEAM) has been spearheading CRISPR-based editing that facilitates the improvement of precocious familial medicines.

While we admit the imaginable of BEAM arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 15 Most Promising Mid-Cap Healthcare Stocks Under $50 and 11 Most Promising Small-Cap Industrial Stocks Under $50.

Disclosure: None. This nonfiction is primitively published astatine Insider Monkey.